These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 25835268)

  • 21. Determination of the composition of counterfeit Heptodin tablets by near infrared chemical imaging and classical least squares estimation.
    Lopes MB; Wolff JC; Bioucas-Dias JM; Figueiredo MA
    Anal Chim Acta; 2009 May; 641(1-2):46-51. PubMed ID: 19393365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards a real time release approach for manufacturing tablets using NIR spectroscopy.
    Pestieau A; Krier F; Thoorens G; Dupont A; Chavez PF; Ziemons E; Hubert P; Evrard B
    J Pharm Biomed Anal; 2014 Sep; 98():60-7. PubMed ID: 24880992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of disintegrant efficacy with fractal dimensions from real-time MRI.
    Quodbach J; Moussavi A; Tammer R; Frahm J; Kleinebudde P
    Int J Pharm; 2014 Nov; 475(1-2):605-12. PubMed ID: 25234864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissolution testing of isoniazid, rifampicin, pyrazinamide and ethambutol tablets using near-infrared spectroscopy (NIRS) and multivariate calibration.
    de Oliveira Neves AC; Soares GM; de Morais SC; da Costa FS; Porto DL; de Lima KM
    J Pharm Biomed Anal; 2012 Jan; 57():115-9. PubMed ID: 21908131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of artificial neural networks for Process Analytical Technology-based dissolution testing.
    Nagy B; Petra D; Galata DL; Démuth B; Borbás E; Marosi G; Nagy ZK; Farkas A
    Int J Pharm; 2019 Aug; 567():118464. PubMed ID: 31252145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput NIR-chemometric methods for chemical and pharmaceutical characterization of sustained release tablets.
    Porfire A; Filip C; Tomuta I
    J Pharm Biomed Anal; 2017 May; 138():1-13. PubMed ID: 28171787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Robust calibration design in the pharmaceutical quantitative measurements with near-infrared (NIR) spectroscopy: Avoiding the chemometric pitfalls.
    Xiang D; Berry J; Buntz S; Gargiulo P; Cheney J; Joshi Y; Wabuyele B; Wu H; Hamed M; Hussain AS; Khan MA
    J Pharm Sci; 2009 Mar; 98(3):1155-66. PubMed ID: 18702120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissolution of tablet-in-tablet formulations studied with ATR-FTIR spectroscopic imaging.
    Wray PS; Clarke GS; Kazarian SG
    Eur J Pharm Sci; 2013 Mar; 48(4-5):748-57. PubMed ID: 23291036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of mefenamic acid polymorphs in commercial tablets using chemometric coupled to MIR and NIR spectroscopies. Prediction of dissolution performance.
    Antonio M; Maggio RM
    J Pharm Biomed Anal; 2018 Feb; 149():603-611. PubMed ID: 29202439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of liquisolid formulations on dissolution of naproxen.
    Tiong N; Elkordy AA
    Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functionality of disintegrants with different mechanisms after roll compaction.
    Berkenkemper S; Keizer HL; Lindenberg M; Szepes A; Kleinebudde P
    Int J Pharm; 2020 Jun; 584():119434. PubMed ID: 32439584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of a newly developed portable NIR imaging device to monitor the dissolution process of tablets.
    Ishikawa D; Murayama K; Awa K; Genkawa T; Komiyama M; Kazarian SG; Ozaki Y
    Anal Bioanal Chem; 2013 Nov; 405(29):9401-9. PubMed ID: 24196120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Near infrared spectroscopy to monitor drug release in-situ during dissolution tests.
    Sarraguça MC; Matias R; Figueiredo R; Ribeiro PR; Martins AT; Lopes JA
    Int J Pharm; 2016 Nov; 513(1-2):1-7. PubMed ID: 27601336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of NIR-chemometric methods for chemical and pharmaceutical characterization of meloxicam tablets.
    Tomuta I; Iovanov R; Bodoki E; Vonica L
    Drug Dev Ind Pharm; 2014 Apr; 40(4):549-59. PubMed ID: 23594301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of different fast melting disintegrants by means of a central composite design.
    Di Martino P; Martelli S; Wehrlé P
    Drug Dev Ind Pharm; 2005 Jan; 31(1):109-21. PubMed ID: 15704862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fast assessment of the surface distribution of API and excipients in tablets using NIR-hyperspectral imaging.
    Franch-Lage F; Amigo JM; Skibsted E; Maspoch S; Coello J
    Int J Pharm; 2011 Jun; 411(1-2):27-35. PubMed ID: 21419207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of modification and incorporation techniques on disintegrant properties of wheat (Triticum aestivum) starch in metronidazole tablet formulations.
    Odeniyi MA; Ayorinde JO
    Polim Med; 2014; 44(3):147-55. PubMed ID: 25696939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct quantification and distribution assessment of major and minor components in pharmaceutical tablets by NIR-chemical imaging.
    Amigo JM; Ravn C
    Eur J Pharm Sci; 2009 May; 37(2):76-82. PubMed ID: 19429413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of intra- and extragranular microcrystalline cellulose in tablet dissolution.
    Li JZ; Rekhi GS; Augsburger LL; Shangraw RF
    Pharm Dev Technol; 1996 Dec; 1(4):343-55. PubMed ID: 9552318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of tablet solubility and hygroscopicity on disintegrant efficiency in direct compression tablets in terms of dissolution.
    Gordon MS; Chowhan ZT
    J Pharm Sci; 1987 Dec; 76(12):907-9. PubMed ID: 3440935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.